"Viremia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The presence of viruses in the blood.
Descriptor ID |
D014766
|
MeSH Number(s) |
C02.937 C23.550.470.790.500.900
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Viremia".
Below are MeSH descriptors whose meaning is more specific than "Viremia".
This graph shows the total number of publications written about "Viremia" by people in this website by year, and whether "Viremia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2003 | 1 | 2 | 3 |
2004 | 3 | 0 | 3 |
2005 | 0 | 2 | 2 |
2006 | 0 | 1 | 1 |
2007 | 1 | 2 | 3 |
2008 | 0 | 2 | 2 |
2009 | 1 | 2 | 3 |
2010 | 2 | 0 | 2 |
2011 | 1 | 3 | 4 |
2012 | 3 | 1 | 4 |
2014 | 2 | 4 | 6 |
2015 | 3 | 1 | 4 |
2016 | 4 | 3 | 7 |
2017 | 36 | 41 | 77 |
2018 | 44 | 60 | 104 |
2019 | 8 | 12 | 20 |
2020 | 12 | 6 | 18 |
2021 | 9 | 4 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Viremia" by people in Profiles.
-
SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19. J Med Virol. 2022 01; 94(1):147-153.
-
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice. Viruses. 2021 08 20; 13(8).
-
Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19. J Med Virol. 2021 Dec; 93(12):6788-6793.
-
Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study. J Autoimmun. 2021 09; 123:102703.
-
Severe COVID-19 in patients with hematological cancers presenting with viremia. Ann Oncol. 2021 10; 32(10):1297-1300.
-
Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study. PLoS One. 2021; 16(7):e0254167.
-
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. J Clin Invest. 2021 07 01; 131(13).
-
Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology. PLoS Pathog. 2021 07; 17(7):e1009381.
-
Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic. Mol Neurobiol. 2021 Sep; 58(9):4694-4715.
-
Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients. Sci Rep. 2021 06 23; 11(1):13134.